To hear about similar clinical trials, please enter your email below
Trial Title:
Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis
NCT ID:
NCT06244420
Condition:
Myoepithelioma
Conditions: Official terms:
Myoepithelioma
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
Clinical data review
Description:
review the medical records, radiological imaging, and histological data of these patients
Arm group label:
Patients
Summary:
The purpose of the study is to assess whether there is a correlation between imaging and
histology with prognosis in patients with soft tissue and bone MC from the archives of
the Rizzoli Orthopaedic Institute all the patients with a histological diagnosis of soft
tissue or bone malignant myoepithelioma treated from 1998 to 2021
Criteria for eligibility:
Study pop:
patients with soft tissue and bone MC
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Male and female patients treated at Rizzoli Orthopaedic Institute between 01 Jan
1998 and 31 Dec 2021
- Age ≥ 2 years old
- Diagnosis of soft tissue or bone malignant myoepithelioma (MC-SB)
- Patients with available clinical and imaging data
Exclusion Criteria:
- At least one inclusion criterion not met
Gender:
All
Minimum age:
2 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
IRCCS Itituto Ortopedico Rizzoli
Address:
City:
Bologna
Zip:
40136
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Costantino Errani, MD
Start date:
January 10, 2024
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Istituto Ortopedico Rizzoli
Agency class:
Other
Source:
Istituto Ortopedico Rizzoli
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06244420
